Science Funds Feed the Economy

New data reveal that a sizable chunk of the investment in science is spent on materials and services from U.S. companies.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, PEN WAGGENERAs federal dollars leave Washington and head for universities, they fan out to have a broad economic impact. A report published in Science today (April 4) shows that a considerable proportion of the money going into scientific investments actually leaves campus to pay for goods and services at U.S. firms. “The main purpose of science funding isn't as a jobs or stimulus program, but this study shows there are also major short-term economic benefits to science funding,” Bruce Weinberg, a coauthor of the report, said in a press release.

Weinberg, an economist at Ohio State University, and his colleagues tracked the fate of investments at nine large, midwestern universities. In total, the schools received $7 billion in research and development funding in 2012, about half of which came from the federal government. The economists found that $1 billion of that investment was spent on equipment and services from U.S. vendors. Of those expenditures, 16 percent stayed in the university’s home county; another 16 percent remained within the state.

Weinberg’s results also shed light on a diverse workforce. Among those employed by federal research funds, a minority—just about 20 percent—were faculty members, while the rest comprised staff and students, for the most part, along with the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies